A total of 38 neutralization escape mutant viruses have been selected from a cloned stock of human rhinovirus serotype 2 (HRV-2), using either of two monoclonal antibodies (MAbs) which recognize overlapping epitopes as judged by competition binding. The mutant viruses were analysed for their sensitivity to a panel of antiviral MAbs by antibody binding and virus neutralization assays. The position and nature of the selected mutations was determined by sequencing of the virus RNAs, and the location of the substituted amino acids on the three-dimensional structure of the virus predicted from the co-ordinates determined for the closely related HRV-1A. Escape from neutralization could be attributed to single amino acid substitutions in all but one case, which had a deletion of four amino acids. In all cases in which the same mutation was found more than once, these mutations were transitions. The ratio of transition to transversion mutations was about 5 : 1 overall or about 1.7:1 if only unique substitutions are considered. Each antibody selected for a discrete cluster of mutations and the area of these clusters was considerably less than that determined to be in contact with antibodies from X-ray crystallographic analyses of antibody/protein complexes. One mutation did not occur within the cluster of others selected with the same antibody. This substitution occurred at the base of a small loop and may cause conformational changes at the virus surface.
Introduction
Studies relating to the mechanisms whereby antibodies bind to their respective antigens have produced conflicting evidence, depending on the method of investigation, as to the precise nature of paratope/epitope interactions. There are numerous examples which show that the binding of monoclonal antibodies (MAbs) to proteins can be prevented by single amino acid substitutions within the epitope (e.g. Wiley & Skehel, 1987; Appleyard et al,, 1990; Page et al., 1988) and mapping studies using synthetic peptides have indicated that six or seven amino acids are sufficient for binding to many antibodies (Geysen et al., 1984) . Furthermore, studies with minimal length binding peptides in which each of the amino acids is substituted in turn with all other 19 possibilities have suggested that as few as two or three residues may be critical for antibody recognition (Getzoff et al., 1987) . In addition, synthetic peptides representing linear stretches of primary amino acid sequence have, in many cases, been shown to elicit antibodies capable of recognizing the native form of the protein from which the sequence was derived (reviewed by Milich, 1989) . In contrast to these indications that few or very few amino acids are essential for antibody recognition of proteins, structural studies of antibody/ antigen complexes by X-ray crystallographic techniques have shown that an antibody footprint is approximately 25 x 20 ,~ and that the area of epitope/paratope interaction is 600 to 700 ~2, involving 16 to 20 amino acids on each surface (Colman et al., 1987; Amit et al., 1986; Mariuzza et al., 1987; Sheriffet al., 1987) . Moreover, the reactivity of most antibodies raised to native proteins is abolished by denaturation of the antigen, suggesting that topographically complex features of epitopes are important for antibody binding.
We have chosen to investigate these apparent paradoxes using MAbs to human rhinovirus serotype 2 (HRV-2). The human rhinoviruses belong to the rhinovirus genus of the family Picornaviridae and are major causative agents of the common cold. Despite general similarities in the physicochemical properties of viruses within the genus, there is great antigenic diversity, and over 100 serotypes have been identified. This feature makes them good candidates for studying the molecular features of antigenic structure and variation in a biologically relevant system, since the viruses can clearly tolerate a high degree of sequence variation without 0001-1046 © 1993 SGM compromising virion structure and infectivity. In addition, the structures of HRV-14 and HRV-1A (which is closely related by sequence to HRV-2) haveo been determined to a resolution of 2.9 A and 3"2 A, respectively, by X-ray crystallography, and the structure of HRV-2 is under investigation (D. Stuart, personal communication) . Also, the availability of infectious molecular clones of representative rhinoviruses offers the potential for creating defined mutations, to complement those which can be selected from virus populations, in order to study their effects on antigenic structure and antibody binding.
A panel of MAbs to HRV-2 has been generated in our laboratory, and the epitopes they recognize have been mapped by competition binding studies and sequence analysis of neutralization-resistant variant viruses. The two MAbs, 806 and 807, chosen for the studies reported here recognize overlapping epitopes, as judged by competitive binding assay (Appleyard et al., 1990) . These epitopes are within antigenic site B, as defined by Appleyard et al. (1990) , which lies to the south side of the 'canyon' (Rossmann et al., 1985) and is partly analogous to antigenic site Nim II of HRV-14 (Rossmann et al., 1985) . Although site B of HRV-2 comprises residues from VP1, 2 and 3, only residues of VP1 and 3 have been shown to contribute to the epitopes recognized by MAbs 806 and 807. Although the epitopes recognized by these two MAbs overlap they are not identical, since the substituted amino acids in antibody-selected variant viruses were at different positions on the capsid and did not always confer resistance to both antibodies. It was therefore of interest to determine from a larger panel of neutralization escape viruses whether the two MAbs would independently select for identical substitutions. As a first step in this investigation we have selected and partially sequenced a total of 38 neutralization-resistant variant viruses from a cloned virus stock which had not previously been subjected to antibody pressure.
Methods
Selection of MAb-resistant mutants. HRV-2 (from the Common Cold Unit Salisbury, U.K.) was plaque-purified three times and then passaged three times in OH5 HeLa cells to produce the stock virus. One ml of this virus stock, containing approx. 2 x 105 p.f.u., was reacted with 1 ml of either undiluted MAb 806 or a 1/25 dilution of MAb 807 (Appleyard et al., 1990) for 2 h at 36 °C. The virus antibody mixtures were used to infect cell monolayers at a dilution of 1/l or 1/10, and the cells overlaid with agar containing either a 1/10 dilution of MAb 806 or a 1/75 dilution of MAb 807. Large plaques, representing neutralization-resistant mutant viruses, were picked after 3 days incubation at 34 °C and titrated in HeLa cells, using the appropriate MAb in the overlay. After 3 days incubation a large plaque was picked from each plate and passaged once in HeLa cells to provide stock mutant virus for characterization. The nomenclature used to identify the resistant viruses is 806/1-n and 807/1-n for those selected by MAbs 806 and 807, respectively, in order to distinguish it from 'R' nomenclature used in earlier MAb characterization studies (Appleyard et al., 1990) .
Characterization of escape mutants'
(i) Capture ELISA. ELISA plates (Nunc) were coated overnight with rabbit polyclonal anti-HRV-2 IgG diluted 1:1000 in sodium carbonate buffer pH 8.3. After washing with 0"7 % casein in Tri~HC1 pH 7-6, dilutions of mutant viruses were added and incubated for 2 h at 36 °C. After further washing the bound antigen was reacted with a panel of murine MAbs (see Appleyard et al., 1990) and bound antibody detected with rabbit anti-mouse antibody conjugated to horseradish peroxidase.
(ii) Neutralization assays (a) Plaque reduction. Aliquots of 100 gl of the mutant viruses, containing 3x 105p.f.u./ml in PBS plus 10% tryptose phosphate broth, were incubated for 2 h at 36 °C with various dilutions of the panel of MAbs tested by capture ELISA. The neutralization titre was taken as the reciprocal of the maximum antibody dilution that reduced the virus plaque count by 90 %. A virus was considered to be resistant if neutralization required > 10-fold more antibody as compared to the parental virus. Viruses which required two-to 10-fold more antibody compared to the parental virus were considered to be partially resistant.
(b) Plaque inhibition. The selected mutant viruses were plaqued in HeLa cells using overlays containing the same panel of MAbs used for capture ELISA. After 3 days incubation at 34 °C plaques were visualized by staining with neutral red. Viruses that produced plaques of the same size (about 4 mm diameter) in the presence or absence of MAb were considered to be resistant to that MAb; those producing only small plaques (< 1 mm diameter) in the presence of MAb were considered to be sensitive. Viruses which produced plaques of intermediate size were considered to be partially resistant. MAbs 1105 and 1107, which were used in binding assays, could not be used in neutralization assays as their neutralization titres were too low.
Virus purification and RNA sequencing. The stock viruses were grown in HeLa cell monolayers in 850 cm 2 roller bottles until there was complete c.p.e. After freezing and thawing twice the harvests were clarified and equal volumes of saturated ammonium sulphate added to the supernatants. After centrifugation at 2000 g for 1 h the precipitates were resuspended in 0.1 M-Tris HC1, 0.1 N-NaCI, pH 7.6. Viruses were pelleted by centrifugation at 130000g for 2h and resuspended overnight in 10 mM-Tris-HC1, 1 mM-EDTA, 0.1% 2-mercaptoethanol, 1% NP40, pH 7-6. Sarkosyl was added to 0.5 % and the viruses were purified on 15 to 45 % sucrose density gradients (2 h at 150000 g) and detected by absorbance at 260 nm. The peak fractions were pooled and extracted twice with phenol/choloroform/SDS (1:1:0-1% by vol.), ethanol-precipitated, dried and stored in diethylpyrocarbonate-treated water at -70 °C.
Sequencing was carried out by primer extension using dideoxynucleotides for chain termination as described previously (Caton et al., 1982; Appleyard et al., 1990) .
Computer graphics. The positions of the amino acid changes in the escape mutants were located on the virus surface by analogy with the structure of HRV-IA from co-ordinates provided by M. Rossmann (Kim et al., 1989) using the computer graphics program Frodo (Jones, 1985) .
Western blot analysis. The proteins of purified HRV-2 were separated on 12.5 % polyacrylamide gels using the method described by Laemmli (1970) . They were electrophoretically transferred to nitrocellulose (Towbin et al., 1979) and reacted with antiserum (diluted 1/1000) in the presence of 5 % dried milk in PBS (Johuson et al., 1984) . Bands were visualized using ~SI-labetled Protein A (Amersham). 
Results

Characterization of escape mutants by ELISA and neutralization
Virus mutants which had been selected for their resistance to neutralization by either of two MAbs (806 or 807) were characterized by their reactions in capture ELISA with a panel of MAbs described previously (Appleyard et al., 1990) . Twelve distinct groups were distinguished (Table 1 ) and mutants representative of these groups were examined using a selection of the MAbs in both plaque reduction and plaque inhibition assays (Table 2) . In general, the agreement between the results obtained with the different analytical tests was excellent and, as expected, those virus mutants which did not react in the capture ELISA with a given antibody were not neutralized by that antibody. However, mutant 806/15 reacted with MAb 808 in ELISA and was neutralized in the plaque inhibition assay but not in the plaque reduction assay ( Table 2 ), suggesting that the two assay systems may reflect different mechanisms of neutralization, e.g. aggregation versus inactivati6n. Thus, resistance to neutralization does not necessarily imply inability of the antibody to bind to the virus. However, it should be appreciated that the ELISA system detects captured virus, which may be distorted by reaction with the capture antibody (McCullough et al., 1985) .
Identification of substitutions conferring resistance to neutralization
The 38 mutant viruses selected in the initial screening were analysed by primer extension sequencing. The primers chosen permitted sequencing of the regions of the genome in which substitutions had been demonstrated in previously selected mutants from MAbs 806 and 807 (Appleyard et al., 1990) . The results (Table 3) can be summarized as follows.
(i) Many of the isolates were sibling mutations, for example D-+ G at VP3 59.
(ii) Different amino acid substitutions at specific positions can produce mutant viruses with apparently identical phenotypes, e.g. D-+ G and D-+ A at VP3 59, or with distinguishable phenotypes, c.g T -+ I and T ~ A at VPt 276.
(iii) A variety of changes allowed the virus to escape from MAb neutralization. Most of these were point mutations resulting in a change of one amino acid. However, in one case, mutant 806/15, a four amino acid deletion had occurred. Western blot analysis with antipeptide antisera was used to confirm the implication from sequencing that mutant 806/15 had a four amino acid deletion of residues VP1 264 to 267. Antiserum to 
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Location of substituted amino acids on the virus structure
As the three-dimensional structure of HRV-2 has yet to be solved, the positions on the virus of the substitutions selected by MAbs 806 and 807 were estimated using coordinates for the closely related virus HRV-1A (Fig. 1 ) Each MAb selected for substitutions which clustered at discrete exposed regions of the capsid structure. Substitutions were found at each of the positions identified in an earlier, less extensive study, which was performed with a different cloned stock of neutralization-sensitive virus (Appleyard et aL, 1990) . The mutations selected by MAb 807 mapped exclusively to one of these clusters, and all but one of those selected with MAb 806 made up the other. However, one mutation selected with this antibody (VP3 62 in mutant 806/8) was close to those selected with MAb 807 and conferred resistance to both antibodies. This mutation appears to be situated at the base of a small surface-oriented loop ( Fig. 1 b and c) . The point mutations which confer resistance to both MAbs 806 and 807 (VP3 59 and 62 and VP1 269) are located at the closest positions between the two clusters, suggesting that they may define the regions of overlap between the two epitopes. The deletion of residues VP1 264 to 267 in 806/15 is very likely to affect the conformation of VP1 269, which may account for its resistance to neutralization by MAb 807.
Discussion
X-ray crystallographic analyses of complexes between protein antigens and antibody FAb fragments have shown that as many as 20 amino acid side chains of an epitope are in close contact with the corresponding antibody paratope. However, studies with naturally occurring or artificially selected antigen sequence variants have shown that single amino acid substitutions can dramatically reduce antibody binding as measured by serological techniques or virus neutralization. It is consequently of interest to determine the number and location of those residues in an epitope which are critical for antibody binding, and this is of particular importance for viruses since neutralizing antibodies are crucial for the control and prevention of infection. As a preliminary step in analysing this problem we have studied a number of neutralization escape viruses selected from a stock of HRV-2 with either of two MAbs previously shown to recognize overlapping epitopes, as assessed by competitive binding assays (Appleyard et al., 1990) . Although this approach can provide information as to which epitopic residues are important for antibody recognition it has an important limitation. It cannot be concluded that positions at which substitutions are not selected are of minor importance for antibody binding, since it is possible that such substitutions would be lethal to the virus. Indeed, site-directed mutagenesis of an exposed residue in neutralization site 3B of poliovirus type 1 resulted in virus which was altered in the folding and processing of the precursor to the structural proteins and in its thermal stability (Reynolds et at., 1992) . This problem is probably minimal for the rhinoviruses since there are over 100 serotypes, in contrast to the three found in poliovirus, which suggests that a broad range of sequence variations can be tolerated. Furthermore, analysis of the known capsid protein sequences for different serotypes of the virus in relation to the X-ray crystallographic structure of H RV-1A suggests that most (perhaps all) of the surface-oriented residues can mutate without detriment to the virus (D. Stuart, personal communication).
All of the 38 resistant viruses selected with either of the two MAbs had amino acid substitutions at regions of the capsid proteins that were anticipated both from earlier work and from the structure of the virus. It is therefore unlikely that any substitutions that may have been present outside the sequenced regions were of significance for the neutralization resistance phenotypes. Most of the mutations were of a non-conservative nature and introduced marked changes in charge, polarity or bulk. All but one of the mutations were the results of single nucleotide substitutions, 31 of which were transitions and six of which were transversions. These figures become 35 and eight, respectively, if the mutations identified in our earlier studies are included (Appleyard et al., 1990) . The remaining mutant was of interest since four amino acids had been deleted from VP1 (residues 264 to 267). Many of the substitutions observed were present in several independently selected resistant variants and it is likely that some or all of these were siblings derived from single mutational events. If only unique substitutions are considered, the ratio of transition to transversion mutations is about 1"7 : 1, a figure similar to that observed in a study of MAb-selected variants of poliovirus (Page et al., 1988) .
Although the only way to ensure that each variant studied arose from a single mutation event is to select each mutant from an independent sensitive plaque, it is interesting that all of the multiply represented mutations were transitions. It is therefore likely that some of these were independent mutations and that the true ratio of transition to transversion mutations for HRV may be greater than 1.7 : 1.
The 20 neutralization-resistant viruses selected with MAb 807 included six different mutations at four amino acid positions, VP3 58, 59, and VP1 276 and 278. By analogy with the structure determined for HRV-1A, these four residues form a small highly exposed cluster at the virus surface and together represent an area of about 60 ~2. The 18 resistant viruses selected with MAb 806 had a total of 10 substitutions, at six positions, VP1 264, 266, 267, 268, 269 and VP3 62 , in addition to mutant 806/15 in which residues VP1 264 to 267 were deleted. With the exception of the mutation at VP3 62 (806/8), all of the substituted residues formed a small, highly exposed cluster representing an area of about 60 A 2 located about 15 ,~ from the patch of mutations selected with MAb 807. However, position VP3 62 lies close to the patch of mutations selected with MAb 807, and the substitution at this position conferred resistance to both MAbs 806 and 807. By analogy with the structure of HRV-1A, residue VP3 62 appears to underlie a small surfaceoriented loop, and it is possible that mutations at this position may influence the conformation of the loop and prevent the MAbs binding by steric hindrance. X-ray diffraction data from crystals of parental HRV-2 and mutant 806/8 are being analysed (D. Stuart, personal communication) and it is hoped that the resolution of the structures will throw light on the mechanisms of resistance due to this mutation.
When tested for their ability to bind a panel of seven MAbs, previously shown to map to the same region on the virus capsid (Appleyard et al., 1990) , the mutant viruses could be separated into 12 groups. In cases where different substitutions were seen at the same residue the position rather than the nature of the substitution appeared to dictate the phenotype of the mutant virus. An exception to this rule was provided by mutant 806/9 (group 7), which was partially resistant to binding and neutralization by MAb 807, whereas mutant viruses with different substitutions at the same position (VP1 269) were not. Another interesting feature of this mutant was its resistance to neutralization by MAb 808, although no reduction in binding of this antibody could be detected by capture ELISA. A similar phenomenon was seen with the deletion mutant 806/15, which was resistant to direct neutralization by all of the MAbs tested but still bound MAb 808 in ELISA.
In all, four groups of mutant viruses displayed a degree of cross-resistance to both MAbs 806 and 807. The substitution of N for I at position VP3 62 (806/8), R for S at position VP1 269 (806/9) and the deletion of VP1 264 to 267 (806/15) have already been discussed. The fourth group involves those viruses with substitutions at position VP3 59 (806/2, 12, 13, 14 and 10), which is the closest of the mutated residues selected by MAb 806 to the cluster of substitutions selected by MAb 807. It is particularly interesting that these mutants constituted 25 % of all those selected with MAb 807 but were not represented in the panel of resistant viruses selected with MAb 806.
A similar study of influenza virus mutants selected with a MAb which recognized an epitope of the neuraminidase protein has been reported recently (Air et al., 1990) and comparable conclusions can be drawn from the two studies. These are that the specificity of antibody binding to its antigen is determined primarily by the nature and orientation of a small cluster of epitopic residues. The remainder of the contacting surfaces must be sterically compatible but are not of prime importance in determining binding. This would provide an explanation of how synthetic peptides can, in some instances, induce virus-neutralizing antibody. This would demand that such peptides can display, at least in certain conformations, a small array of residues mimicking the core epitopic cluster present on the viral antigen. The polyclonal nature of an anti-peptide response would make it likely that a portion of the appropriate specificity antibodies would be sterically compatible with binding to the virus protein surface. Such an explanation could account for the observations that anti-peptide antibodies can, in some cases, neutralize a range of antigenically distinguishable virus strains (Parry et al., 1989) . In this situation the polyclonal nature of the anti-peptide response may provide a range of antibody species which share a core epitope recognition feature but which differ in the steric compatibility of the remainder of their paratopes. Further work involving structure determination and site-directed mutagenesis of infectious virus clones is required to substantiate and extend the conclusion that can be drawn from the results presented here.
